Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 05'th Aug 2025
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:50am, Tuesday, 05'th Aug 2025
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Allergan Aesthetics Unveils the New Faces of Natrelle® and Real Stories of Empowerment and Transparency
08:00am, Tuesday, 05'th Aug 2025
Nine women from across the U.S. share their personal experiences with breast augmentation and reconstruction with Natrelle® – celebrating confidence, self-expression, and restoration. IRVINE, Cal
The Big 3: ABBV, ETSY, VRT
12:34pm, Monday, 04'th Aug 2025
Mike Shorr (@ProsperTradingAcademy) walks through a pair of stocks he sees set up for a swing breakout: AbbVie (ABBV) and Etsy Inc. (ETSY). For both, he demonstrates an example options trade using a c
AbbVie Raises 2025 Outlook After Q2 Beat
11:23am, Monday, 04'th Aug 2025
AbbVie (ABBV 0.17%) reported second quarter 2025 results on July 31, 2025, delivering adjusted EPS of $2.97 (up $0.11 from guidance midpoint) and net revenues of $15.4 billion (up $400 million from ex
How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?
09:15am, Monday, 04'th Aug 2025
AbbVie's Q2 results show Skyrizi and Rinvoq powering growth, offsetting Humira declines and lifting 2025 sales outlook.
If You'd Invested $1,000 in AbbVie (ABBV) Stock 10 Years Ago, Here's How Much You'd Have Today
09:00am, Sunday, 03'rd Aug 2025
Spoiler: You would have done well -- and even better if you'd reinvested your dividends.
3 Unstoppable Stocks to Buy in August
06:45am, Saturday, 02'nd Aug 2025
The "it" factor. Some stocks have it.
3 Dividend Champion Stocks I'm Watching in 2025
05:41am, Saturday, 02'nd Aug 2025
What does it take to be a Dividend Champion? A company must increase its dividend for at least 25 consecutive years for its stock to make the list.
Why AbbVie Stock Flew Higher on Friday
06:02pm, Friday, 01'st Aug 2025
A bellwether stock in the lately rather up-and-down pharmaceutical sector, AbbVie (ABBV 3.31%) finished the trading week in style. The company's shares closed more than 3% higher in price thanks in no
AbbVie Soars On Skyrizi And Rinvoq Strength, Outpacing Humira Erosion
02:04pm, Friday, 01'st Aug 2025
On Thursday, AbbVie Inc. ABBV reported second-quarter 2025 sales of $15.42 billion on Thursday, beating the consensus of $14.98 billion.
Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.
Dividend Aristocrats: 4 Companies That Surpass Market Volatility With 25 Plus Years of Growth and Superior Yields
08:32am, Friday, 01'st Aug 2025
Dividend Aristocrats are the top option for income driven investors.
Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb
08:31am, Friday, 01'st Aug 2025
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing glo
President Trump demands drugmakers slash prices within 60 days
06:54am, Friday, 01'st Aug 2025
CNBC's Joe Kernen reports on the latest news.
